References
- Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Clin Exp Thyroid. 2011;7(4):8. doi:10.14341/ket2011748-18.
- Ratcliffe GE, Cooke S, Fogelman I, Maisey MN. Radioiodine treatment of solitary functioning thyroid nodules. Br J Radiol. 1986;59(700):385–387. doi:10.1259/0007-1285-59-700-385.
- Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–1214.doi:10.1089/thy.2009.0110.
- Mcdermott MT, Woodmansee WW, Haugen BR, Smart A, Ridgway EC. The management of subclinical hyperthyroidism by thyroid specialists. Thyroid. 2003;13(12):1133–1139. doi:10.1089/10507250360731532.
- Tollin SR, Fallon EF, Mikhail M, Goldstein H, Yung E. The utility of thyroid nuclear imaging and other studies in the detection and treatment of underlying thyroid abnormalities in patients with endogenous subclinical thyrotoxicosis. Clin Nucl Med. 2000;25(5):341–347. doi:10.1097/00003072-200005000-00004.
- Bomeli SR, Lebeau SO, Ferris RL. Evaluation of a thyroid nodule. Otolaryngol Clin North Am. 2010;43(2):229–238. doi:10.1016/j.otc.2010.01.002.
- Görges R, Kandror T, Kuschnerus S, et al. Scintigraphically “hot” thyroid nodules mainly go hand in hand with a normal TSH. Nuklearmedizin. 2011;50:179–188.
- Treglia G, Trimboli P, Verburg FA, Luster M, Giovanella L. Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule. Eur J Clin Invest. 2015;45(7):739–744. doi:10.1111/eci.12456.
- Burch HB, Cooper DS. Management of graves disease. Jama. 2015;314(23):2544. doi:10.1001/jama.2015.16535.
- Kang AS, Grant CS, Thompson GB, Heerden JAV. Current treatment of nodular goiter with hyperthyroidism (Plummers disease): surgery versus radioiodine. Surgery. 2002;132(6):916–923. doi:10.1067/msy.2002.128691.